Biotech companies are seeing significant pre-market activity this Monday.
Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses.
In the Green - Premarket Gainers
On Monday, the following stocks were trading significantly higher in the premarket session.
1. Gelteq Limited. (GELS) - up 46% at $1.432. Park Ha Biological Technology Co., Ltd. (BYAH) - up 20% at $1.773. Upexi, Inc. (UPXI) - up 10% at $0.994. BiomX Inc. (PHGE) - up 10% at $0.595. Metagenomi Therapeutics, Inc. (MGX) - up 8% at $1.306. Lexeo Therapeutics, Inc. (LXEO) - up 7% at $4.677. Longeveron Inc. (LGVN) - up 7% at $0.848. ProQR Therapeutics N.V. (PRQR) - up 6% at $1.539. BioVie Inc. (BIVI) - up 6% at $1.7210. Allarity Therapeutics, Inc. (ALLR) - up 4% at $1.48
In the Red - Premarket LosersThe following stocks were trading lower in the premarket session on Monday.
1. Elicio Therapeutics, Inc. (ELTX) - down 62% at $5.792. 20/20 Biolabs, Inc. (AIDX) - down 18% at $0.793. Propanc Biopharma, Inc. (PPCB) - down 9% at $2.074. Moolec Science SA(MLEC) - down 9% at $6.905. CollPlant Biotechnologies Ltd. (CLGN) - down 9% at $0.316. China SXT Pharmaceuticals, Inc. (SXTC) - down 8% at $2.357. Universe Pharmaceuticals INC. (UPC) - down 8% at $2.978. Zhengye Biotechnology Holding Limited. (ZYBT) - down 8% at $0.779. Cyclerion Therapeutics, Inc. (CYCN) - down 7% at $3.0110. Advanced Biomed Inc. (ADVB) - down 7% at $4.20
For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.